The new policy of formula particles accelerates to land!

The prescription ratio of formula particles is not higher than that of decoction pieces

On the whole, Beijing, Anhui, and Hebei’s "Draft for Comments" have put forward roughly the same regulations on standard management, production management, filing management, use management, medical insurance management, and supervision and management of traditional Chinese medicine formula granules, and they all emphasize Chinese medicine formulations particles outside medical institutions may not sell, use of Chinese medicine granules should provincial / municipal centralized drug procurement platform sunshine procurement, online transactions through

However, there are also some differences worthy of attention.

The "Draft for Comment" of Anhui Province puts forward, "Incorporate TCM formula granules into relevant industry development plans, and promote the development of the TCM formula granules industry in combination with the actual development of the industry

Hebei Province "draft" Conditions for the production of Chinese medicine granules Chinese medicine production enterprises should have, including "manufacturers developed more than 400 varieties should be"

Increase production

The tens of billions of high-margin market welcomes major changes

At present, the main leading companies in the traditional Chinese medicine formula granule industry are China Traditional Chinese Medicine and China Resources Sanjiu

China Resources Sanjiu can currently produce more than 600 varieties of single-flavor formula granules.

  Faced with the changes in the competitive environment brought about by the loosening of policies to heat up the traditional Chinese medicine formula granule industry, China Resources Sanjiu said that on the one hand, the company has accelerated the expansion of the construction of medicinal material planting bases, controlled product quality from the source, and ensured the quality and quality of medicinal materials

  According to data from the Prospective Industry Research Institute, the market size of traditional Chinese medicine formula particles increased from 200 million yuan to 10.

  With the liberalization of the policy, the Chinese medicine formula granule market will enter a comprehensive stage of differentiation

  At the same time, major pharmaceutical companies have stepped up to expand production

  Some market participants believe that as the industry is officially liberalized and more pharmaceutical companies enter, competition will become more intense, which will further test the marketing capabilities of companies

Marketing breaks

Realize the granule of traditional Chinese medicine formula from 0 to 1

  Liu Bingxin, a member of the Guangdong Provincial Committee of Chinese Medicine Formula Granules, suggested that, as a late entrant, winning provincial and municipal benchmark hospitals through local advantages and medical insurance restrictions is the focus, followed by expansion of the grassroots market with huge potential

  For hospitals such as grade Chinese medicine hospitals, the promotion of enterprises must focus on solving doctors’ concerns about the difference in efficacy between Chinese medicine decoction pieces and Chinese medicine formula granules, avoiding the problem of "single co-decoction" that is difficult to explain; a comprehensive approach led by Western medicine For hospitals with a weak TCM atmosphere, it is necessary to negotiate with the hospital to develop TCM promotion strategies; for specialized hospitals such as bone injuries, women and children, skin, and tumors, different promotion ideas need to be matched; for primary hospitals with small but scattered terminals, traditional academic Activities are costly and difficult to roll out
.
It can be combined with local agents to organize offline TCM skills improvement training courses, and sign a tuition-free promotion agreement for ordering TCM formula granules with grassroots terminals, effectively tightening customer stickiness and increasing sales
.
  

  With the liberalization of the policy, the Chinese medicine formula granule industry will enter full-scale competition, and supervision will also need to keep up in time
.
In view of the current situation of unstable quality of traditional Chinese medicine formula granules and statutory standards that have yet to be improved, the national level is also making every effort to promote system construction
.
On April 29, the official website of the National Pharmacopoeia Commission published the first batch of 160 Chinese medicine formula granules national drug standards
.
The promulgation of the national standards for Chinese medicine formula granules will help to fully realize the overall quality control of the safety and effectiveness of Chinese medicine formula granules
.
  

  In fact, industry insiders believe that in the general environment of normalized medical insurance control fees, if there is no production scale, intensification, and system technology accumulation to support cost control advantages, and there is no quality assurance ability for the entire industry chain, it is necessary to ensure five or six hundred flavors.
There is no big quality risk in Chinese medicine formula granules, and it is still very challenging.
The layout of related enterprises needs to be cautious
.